PrepTest 67, Section 2, Question 15
Doctor: It is wrong for medical researchers to keep their research confidential, even if the companies for which they work would rather that they do so. If research results are not shared, the development of effective medical treatments may be delayed, and thus humans may suffer unnecessarily.
Doctor: It is wrong for medical researchers to keep their research confidential, even if the companies for which they work would rather that they do so. If research results are not shared, the development of effective medical treatments may be delayed, and thus humans may suffer unnecessarily.
Doctor: It is wrong for medical researchers to keep their research confidential, even if the companies for which they work would rather that they do so. If research results are not shared, the development of effective medical treatments may be delayed, and thus humans may suffer unnecessarily.
Doctor: It is wrong for medical researchers to keep their research confidential, even if the companies for which they work would rather that they do so. If research results are not shared, the development of effective medical treatments may be delayed, and thus humans may suffer unnecessarily.
Which one of the following principles, if valid, most helps to justify the doctor's argument?
Medical researchers should never engage in any behavior that they know will cause humans to suffer.
If the most important moral principle is to prevent human suffering, then it is wrong for medical researchers to keep their research confidential.
Medical researchers should not keep information confidential if it is possible that sharing that information would prevent some unnecessary human suffering.
Medical researchers should always attempt to develop effective medical treatments as rapidly as they can while fulfilling their other moral obligations.
It is wrong for any company to ask its medical researchers to keep their research confidential, if failure to share the research might delay development of effective medical treatments.
0 Comments